The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China
Study Details
Study Description
Brief Summary
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling of congenital heart disease in medical institutions in China, in order to understand the current status and existing problems of prenatal prevention and treatment capacity of congenital heart disease in China, and to obtain corresponding baseline data, so as to provide scientific basis for further improving prenatal screening and diagnosis policies in China.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
With the rapid development of medical imaging technology, the role of ultrasound screening and diagnosis in the prevention and treatment of birth defects is increasingly prominent. Early screening, classified diagnosis, and standardized consultation are the basis for effective prevention and treatment of congenital heart disease. Due to the uneven development of medical resources and medical service levels in the eastern, central, and western regions of China, as well as between urban and rural areas, the ability of prenatal ultrasound screening, diagnosis, and clinical consultation varies greatly, and there is a lack of relevant clinical research data, which makes it difficult to adopt effective intervention measures. This study aims to investigate and analyze the prenatal screening, diagnosis, and consultation abilities of medical personnel in different regions, evaluate the current status and problems of congenital heart disease abilities in various regions, explore a multidisciplinary transfer consultation integrated service mechanism, strengthen comprehensive prevention and control abilities, ensure maternal and infant health.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Liaoning Provincial Maternal and Child Health Hospital Liaoning Provincial Maternal and Child Health Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Shenyang Maternal and Infant Hospital Shenyang Maternal and Infant Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Guangdong Women and Children's Hospital Guangdong Women and Children's Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Guangzhou Women and Children's Medical Center Guangzhou Women and Children's Medical Center |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Guangdong Provincial People's Hospital Guangdong Provincial People's Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Shandong Maternal and Child Health Hospital Shandong Maternal and Child Health Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Fujian Provincial Maternal and Child Health Hospital Fujian Provincial Maternal and Child Health Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Maternal and Child Health Hospital of Hubei Province Maternal and Child Health Hospital of Hubei Province |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Anhui Provincial Maternal and Child Health Hospital Anhui Provincial Maternal and Child Health Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Peking University First Hospital, Ningxia Women and Children's Hospital Peking University First Hospital, Ningxia Women and Children's Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
| Sichuan Maternal and Child Health Hospital Sichuan Maternal and Child Health Hospital |
Combination Product: Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
|
Outcome Measures
Primary Outcome Measures
- The integrity rate of the multi-view acquisition [From June 2023 to Oct 2023]
The integrity rate of the multi-view acquisition
- Negative coincidence rate congenital heart disease screening [From June 2023 to Oct 2023]
Negative coincidence rate congenital heart disease screening
- Positive coincidence rate of congenital heart disease screening [From June 2023 to Oct 2023]
Positive coincidence rate of congenital heart disease screening
- The coincidence rate of multidisciplinary consultation [From June 2023 to Oct 2023]
The coincidence rate of multidisciplinary consultation
Eligibility Criteria
Criteria
Inclusion Criteria:
- All pregnant women and fetuses who underwent prenatal ultrasound examination in the above hospitals were enrolled
Exclusion Criteria:
- Pregnant women not willing to cooperate
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Beijing Anzhen Hospital
Investigators
- Study Chair: Yihua He, MD, Beijing Anzhen Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MCCDTP-CHD